Silicon Valley Bank Archives - Medical Design Sourcing

The biggest medical device VC deals of 2022

Enable Injections, which makes the enFuse device, raised $215 million in January 2022. [Photo courtesy of Enable Injections]

Last year was definitely a slower year for medical device VC deals than the year before.

Biofourmis was the only medical device developer in the 10 largest healthcare VC deals of 2022, according to a ranking provided to Medical Design & Outsourcing by Silicon Valley Bank (SVB).

Because we love devices at Medical Design & Outsourcing, we asked SVB for a ranking of 2022’s largest medical device VC deals after Biofourmis, which raised $325 million in its 2022 series D round. (The year before that, CMR Surgical’s $600 million Series D financing round was the largest medical device VC deal of 2021.)

SVB obliged, once again drawing upon its own proprietary information and data from Pitchbook. The dealmakers include device developers with innovative methods for …

Ranked: The biggest healthcare VC deals of 2022

A company that sends medical teams on house calls had one of the largest venture capital deals of 2022. [Photo courtesy of Dispatch Health]

The $3 billion launch of a biotech focused on cellular rejuvenation was 2022’s largest healthcare venture capital deal in the U.S. and Europe.

That’s according to a ranking provided to Medical Design & Outsourcing by Silicon Valley Bank (SVB), which ranked the deals using its own proprietary information and data from Pitchbook.

The biopharma sector represented three of the 10 largest VC deals. Diagnostics/tools had two deals on the list, taking the No. 2 and 3 spots. The healthtech sector had four deals on the list.

Only one device developer ranked in 2022’s top 10, just like the year before, when CMR Surgical’s $600 million Series D financing round was the fifth-largest deal of 2021. (Healthtech deals dominated the prior-year list by tak…

Surgical robotic developer leads device makers in top healthcare VC deals

CMR Surgical’s Versius system console [Photo courtesy CMR Surgical]

Surgical robotics developer CMR Surgical was the lone medical device maker in the 10 largest healthcare venture capital deals of 2021 in the U.S. and Europe.

That’s according to a ranking provided to Medical Design & Outsourcing by Silicon Valley Bank (SVB), which recently published its annual VC analysis drawing on its own proprietary information and data from Pitchbook.

Cambridge, U.K.–based CMR Surgical raised $600 million in a Series D financing round announced in June. CMR’s Versius surgical robotic system is available in Europe, Australia, India and the Middle East, but has not been approved by the FDA.

CMR Surgical today announced its expansion into Poland as a hub for Central and Eastern Europe, and last week said its robotic system has been used in thoracic surgery, specifically oesophagomyotomies, lobectomies a…

How is COVID-19 affecting medtech deals?

[Image by Cytonn Photography on Unsplash]

Fewer medical device companies are securing their first big venture capital investments — or engaging in large mergers — amid the COVID-19 pandemic, according to recently released reports from Silicon Valley Bank and PwC.

The medical device industry saw 38 Series A investments worth $279 million during the first half of 2020, down from 45 deals worth $408 million during the same period a year ago, according to SVB’s new mid-year “Healthcare Investments and Exits” report.

Meanwhile, PwC reports that the volume and value of medical device M&A deals decreased during the first half of the year. There were 28 medtech M&A deals worth $1.9 billion during the first six months of 2020, versus 38 deals worth $15.4 billion during the previous six months.

The numbers are but another indication that the medical device industry is not immune to…